Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
181 studies found for:    Open Studies | "Blood Platelet Disorders"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Blood Platelet Disorders" (181 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Unknown  Thrombocytopathy in Gaucher Disease Patients
Conditions: Gaucher Disease;   Thrombocytopathy
2 Recruiting Relationship Between Level of Hemoglobin A1c and Platelet Function in Patients Undergoing Cardiac Surgery
Conditions: Diabetes Mellitus;   Complication of Coronary Artery Bypass Graft;   Blood Platelet Disorders
3 Not yet recruiting Use of Proteomics for the Diagnosis of a Platelet-related Bleeding Disorder
Condition: Inherited Platelet Disorders
Intervention: Other: Blood collection for platelet protein samples
4 Not yet recruiting Comparison of the Effects of Gelatine Versus Balanced Crystalloid Solution for Volume Therapy
Conditions: Hemorrhage, Surgical;   Hip Replacement, Total;   Thrombocytopathy
Interventions: Drug: Gelofusine® B. Braun;   Drug: Ringerfundin ® B. Braun
5 Unknown  Safety and Efficacy of Eltrombopag at Escalated Doses
Conditions: Immune Thrombocytopenia;   Platelet Disorder
Interventions: Drug: Eltrombopag;   Drug: Placebo
6 Recruiting Eltrombopag for Inherited Thrombocytopenias
Condition: Inherited Platelet Disorder
Intervention: Drug: Eltrombopag
7 Not yet recruiting Study on the Anti-HPA Antibodies Caused Neonatal Alloimmune Thrombocytopenia in Chinese Pregnant Women
Condition: Neonatal Alloimmune Thrombocytopenia
Intervention: Procedure: Standard clinical treatment, including intravenous immunoglobulin and/or platelet transfusion
8 Not yet recruiting Low VW Activity in Adolescent HMB
Condition: Von Willebrand Factor Deficiency
Interventions: Other: Genetic Analysis;   Other: Medical Record Data Abstraction;   Other: Pictorial Blood Assessment Chart (PBAC) score;   Other: Complete Bleeding Symptom ISTH Bleeding Assessment Tool
9 Not yet recruiting BAX 111 rVWF in Pediatrics
Condition: Von Willebrand Disease
Interventions: Biological: von Willebrand factor (Recombinant);   Biological: Antihemophilic Factor (Recombinant)
10 Not yet recruiting Therapy of Adults Affected by Idiopathic Thrombocytopenic Purpura With Dexamethasone
Conditions: ITP;   Croticosteroid Therapy
Interventions: Drug: High dose Dexamethasone pulses;   Drug: Prednisone
11 Recruiting Treatment of Polycythaemia Vera and Essential Thrombocythaemia: Influence on the Clot Structure
Conditions: Polycythemia Vera;   Thrombocythemia, Essential
Intervention: Drug: No cytoreductive vs cytoreductive drugs
12 Recruiting Eltrombopag for the Treatment of Thrombocytopenia Due to Low- and Intermediate Risk Myelodysplastic Syndromes
Conditions: Myelodysplastic Syndromes;   Thrombocytopenia
Interventions: Drug: Eltrombopag/Revolade;   Other: Placebo
13 Recruiting Platelet Kinetics After Platelet Transfusion for the Placement of a Central Venous Catheter
Conditions: Thrombopenia;   Central Venous Catheter Placement
Intervention: Procedure: Platelets transfusion
14 Recruiting Study of 'Vascular Competence' Profile and Endothelial Activation in the Hemolytic Uremic Syndrome in Children and Adults
Condition: Hemolytic Uremic Syndrome
Intervention: Biological: Extra blood draw samples
15 Recruiting Myeloproliferative Neoplastic Diseases Observatory From Brest
Conditions: Polycythemia Vera;   Essential Thrombocythemia;   Primary Myelofibrosis
16 Recruiting Immune Thrombocytopenia in Pregnancy
Conditions: Immune Thrombocytopenia;   Pregnancy
Intervention: Other: No intervention
17 Not yet recruiting Follow-up Study for Patients Who Completed Study ALX0681-C301 (Post-HERCULES)
Condition: Acquired Thrombotic Thrombocytopenic Purpura
Intervention: Biological: caplacizumab
18 Recruiting Cytopenias Autoimmune: Midi-Pyrenees Register
Condition: Immune Thrombocytopenia
Intervention: Other: no specific intervention
19 Recruiting Association of FcγRIIIA Polymorphism and THPO Expression With Response to Eltrombopag in Refractory ITP Patients
Condition: Immune Thrombocytopenic Purpura (ITP)
Intervention: Drug: Eltrombopag
20 Recruiting Durvalumab in Treating Patients With Primary, Post-Polycythemia Vera, or Post-Essential Thrombocythemia Myelofibrosis
Conditions: Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase;   Primary Myelofibrosis
Interventions: Biological: Durvalumab;   Other: Laboratory Biomarker Analysis

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years